The 28-day, at-home protocol addresses respiratory dysregulation caused by CO2 hypersensitivity, reducing panic attacks and PTSD symptoms that lead to impaired life function and over-utilization of healthcare services.
Freespira named one of Fast Company's 2023 Most Innovative Companies.
The 28-day, at-home protocol addresses respiratory dysregulation caused by CO2 hypersensitivity, reducing panic attacks and PTSD symptoms that lead to impaired life function and over-utilization of healthcare services.